QMENTA News

QMENTA hosts IronTract Challenge with Harvard

QMENTA hosts IronTract Challenge with Harvard

By Paulo Rodrigues | News

QMENTA is pleased to be collaborating with Harvard’s the Athinoula A. Martinos Center for Biomedical Imaging and the University of Rochester in supporting an exciting research challenge open to image...

QMENTA receives ISO 13485:2016 certification for its QMS system

QMENTA receives ISO 13485:2016 certification for its QMS system

By Paulo Rodrigues | News

      QMENTA’s Quality Management System (QMS) is a company-wide new initiative, which has enhanced the quality of our products & services and improved our system on patient safety. We have...

QMENTA appoints Pablo Villoslada, MD, PhD Chief Medical Officer

QMENTA appoints Pablo Villoslada, MD, PhD Chief Medical Officer

By Paulo Rodrigues | News

BOSTON, MA, February 6th 2019 – QMENTA – the data-driven, AI-powered company, that aims to revolutionize the way medical imaging is used in clinical trials and clinical care – welcomes Pablo...

QMENTA to exhibit at ECTRIMS in Berlin, RSNA in Chicago & PCT in Barcelona

QMENTA to exhibit at ECTRIMS in Berlin, RSNA in Chicago & PCT in Barcelona

By Paulo Rodrigues | News

We are proud to announce that we will be exhibiting at: ECTRIMS in Berlin from October 10th to October 12th, booth C12 RSNA in Chicago from November 25th to November 30th, booth 7665 PCT in Barcelona...

QMENTA will provide Data Management and Analysis Services for Amylyx PEGASUS Clinical Trial of AMX0035 for Alzheimer’s Disease

QMENTA will provide Data Management and Analysis Services for Amylyx PEGASUS Clinical Trial of AMX0035 for Alzheimer’s Disease

By Paulo Rodrigues | News

BOSTON, MA & CAMBRIDGE, MA – QMENTA and Amylyx Pharmaceuticals today announced a collaboration to support Amylyx’s upcoming clinical trial of AMX0035 in Alzheimer’s disease. QMENTA will use its...

Early Signs of Brain Ischemia on CT and MR; Can AI Lend a Helping Hand?

Early Signs of Brain Ischemia on CT and MR; Can AI Lend a Helping Hand?

By Paulo Rodrigues | Expertise

A poor functional outcome of stroke patients may be predicted by early signs on CT and MRI. Radiology exams carried out within 6 hours after stroke onset can contain important insights supporting the...

How Deep Learning and Neuroimaging Can Improve Diagnosis in Psychiatric Diseases

How Deep Learning and Neuroimaging Can Improve Diagnosis in Psychiatric Diseases

By Paulo Rodrigues | Expertise

Impact of psychiatric disorders in the world. The World Health Organization estimates that around 450 million people suffer from psychiatric disorders. They predict that one in four people in the...

Award-Winning Neuroimaging Expert Bruce Rosen, MD, PhD joins QMENTA as Scientific Advisor

Award-Winning Neuroimaging Expert Bruce Rosen, MD, PhD joins QMENTA as Scientific Advisor

By Paulo Rodrigues | News

Boston: QMENTA – The innovative platform for clinical trials and research, providing an all-in-one platform that enables secure and compliant data aggregation and transfer in addition to AI-powered...

Stroke detection using radiology AI: a joint project between QMENTA and Quantib

Stroke detection using radiology AI: a joint project between QMENTA and Quantib

By Paulo Rodrigues | Expertise

Stroke is the 5th leading cause of death in the world with numbers reaching up to 615.000 dead in Europe, 800.000 dead in the US and 15 million globally each year.(1–3) The burden of the disease...

QMENTA is going to VivaTech!

QMENTA is going to VivaTech!

By Paulo Rodrigues | News

In only a couple of years, VivaTech has become one of the most innovative events for startups. The third edition will take place in Paris from May 24th – 26th and will once again gather leaders from...